Guggenheim initiated coverage of Oak Street Health with a rating of Neutral
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/12/2023 | $35.00 | Mkt Perform → Outperform | Raymond James |
| 11/21/2022 | Outperform → Mkt Perform | Raymond James | |
| 11/14/2022 | Equal-Weight → Overweight | Morgan Stanley | |
| 9/12/2022 | $32.00 → $29.00 | Buy → Neutral | Goldman |
| 7/26/2022 | Hold | Argus | |
| 6/15/2022 | $26.00 → $18.00 | Buy → Underperform | BofA Securities |
| 5/27/2022 | $60.00 → $26.00 | Outperform | Bernstein |
| 5/27/2022 | $25.00 | Buy | Stifel |
Oak Street Health, Inc. (NYSE:OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced its Board of Directors has cancelled its 2023 Annual Meeting of Stockholders scheduled for Thursday, April 27, 2023, at 8:30 A.M., Central Time (the "Annual Meeting"). This follows the previously announced definitive agreement under which CVS Health Corporation (NYSE:CVS), a leading health solutions company, will acquire Oak Street Health in an all-cash transaction at $39.00 per share, representing an enterprise value of approximately $10.6 billion. Oak Street Health currently anticipates that the transaction wil
Value-Based Care Leaders Oak Street Health and Interwell Health Partner on Joint Venture Oak Street Health (NYSE:OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, and Interwell Health, a kidney care management company that partners with physicians on its mission to reimagine healthcare, today announced the launch of OakWell, a joint venture that will offer the highest-quality primary care to end-stage kidney disease (ESKD) patients directly in the dialysis center. This unique approach to primary care for ESKD patients aims to reduce hospitalizations, increase kidney transplantations, and improve outcomes t
Oak Street Health, Inc. (NYSE:OSH, or the "Company"))), a network of value-based primary care centers for adults on Medicare, today reported financial results for the year ended December 31, 2022. "Our team's commitment and hard work delivered outstanding health outcomes and an unmatched patient experience leading to consistent center-level performance and strong full year results. We remain committed to improving the well-being of our patients, bringing new patients to the Oak Street model, and rebuilding healthcare as it should be," said Mike Pykosz, Chief Executive Officer of Oak Street Health. Full Year 2022 Financial Highlights Total revenues were $2.16 billion, up 51% year over ye
Raymond James upgraded Oak Street Health from Mkt Perform to Outperform and set a new price target of $35.00
Raymond James downgraded Oak Street Health from Outperform to Mkt Perform
Morgan Stanley upgraded Oak Street Health from Equal-Weight to Overweight
Awarded by Energage's Top Workplaces Program Nationally and in Chicago, New York, New Orleans and Oklahoma in 2022 Oak Street Health (NYSE:OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced it has been awarded a Top Workplaces 2022 honor by The Chicago Tribune, amNY Metro, Nola.com and The Oklahoman, in addition to Energage's 2022 Top Workplaces USA award. The Top Workplaces awards are based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC. The anonymous survey uniquely measures 15 culture drivers that are c
Oak Street Health, Inc. (NYSE:OSH, or the "Company"))), a network of value-based primary care centers for adults on Medicare, today reported financial results for its third quarter ended September 30, 2022. "We reported another strong quarter of results driven by the dedication and execution of our team leading to consistent center-level performance. Our focus remains on expanding nationally to bring our model to more patients while greatly improving the health and well-being of the patients we serve, leading to strong financial results and realization of our mission of rebuilding healthcare as it should be," said Mike Pykosz, Chief Executive Officer of Oak Street Health. Third Quarter 20
Oak Street Health, Inc. (NYSE:OSH) will host a conference call on Tuesday, November 8, 2022, at 8:00 AM Eastern Time to review the Company's fiscal third quarter 2022 financial results. A press release announcing the fiscal third quarter results will be issued on Monday, November 7, 2022, after market close. To participate in the Company's live conference call and webcast, please dial (844) 200-6205 for U.S. participants, or +1 (929) 526-1599 for international participants, referencing participant code 255745, or visit the "Events & Presentations" section of https://investors.oakstreethealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the c
SC 13G/A - Oak Street Health, Inc. (0001564406) (Subject)
SC 13G/A - Oak Street Health, Inc. (0001564406) (Subject)
SC 13G/A - Oak Street Health, Inc. (0001564406) (Subject)
15-12G - Oak Street Health, Inc. (0001564406) (Filer)
10-Q - Oak Street Health, Inc. (0001564406) (Filer)
S-8 POS - Oak Street Health, Inc. (0001564406) (Filer)
4 - Oak Street Health, Inc. (0001564406) (Issuer)
4 - Oak Street Health, Inc. (0001564406) (Issuer)
4 - Oak Street Health, Inc. (0001564406) (Issuer)
As a part of a broader coverage of 15 companies in the Healthcare Services sector, Cantor Fitzgerald initiated coverage on CVS Health Corp (NYSE:CVS) with a price target of $87 and an Overweight rating. Once pieced together, CVS, Signify Health, Oak Street Health Inc (NYSE:OSH), and Carbon (JV) can create a flywheel that brings in industry-leading, consumer-facing technology and ease of access, enhanced brand value across commercial and Medicare, higher NPS (net promoter score), and significantly more opportunities. Also Read: New York Governor, Attorney General Ask Three Pharmacy Operators' Commitment Over Abortion Drug Access. The analyst sees potential for a bull scenario of long-ter
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70. Here’s the latest list of major overbought players in this sector. Palisade Bio, Inc. (NASDAQ:PALI) Palisade Bio reported year end 2022 financial results and issued corporate update. “Our team has made great progress executing our operational
Dr. Deb Edberg will focus on provider wellness, further advancing Company's commitment to being a Great Place to Work Oak Street Health (NYSE:OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, named Dr. Deb Edberg as its first Chief Wellness Officer, effective immediately. The new role was created to further support provider wellness and reaffirm the Company's commitment to being a great place to work. "Wellness is not a problem to be solved, but rather an ongoing commitment to our teammates at Oak Street Health," says Dr. Edberg, Chief Wellness Officer at Oak Street Health. "It is paramount that our frontl